David Pittman of Medpagetoday.com reports that the Institute of Medicine (IOM) applauded the NIH’s Clinical and Translational Science Awards (CTSA) Program and its significance to the advancement of clinical and translational research. The CTSA program was created to...
In the wake of the recent commotion surrounding flawed research at Duke University on diagnostic tools based on molecular patterns (“omics” tests), an Institute of Medicine (IOM) panel has issued a report entitled Evolution of Translational Omics: Lessons Learned and...
A report released Feb. 29th by the Institute of Medicine (IOM) provided a review of the benefits of current federal laws that offer incentives for or require drug and biologic developers to conduct pediatric studies. The report also highlighted several areas where...
Single IRB – A Guide to the Common Rule sIRB Mandate
The sIRB requirement is active. Is your study affected?